BRCA1 and BRCA2 are associated with nearly 40% of hereditary BC cases, making their pathogenic variants (PVs) the most common genetic contributors to hereditary breast and ovarian cancer syndrome (HBOC) due to their high penetrance [10,11]. This evidence concerns the gene BRCA2 and breast cancer.